tryptophan has been researched along with Eosinophilia-Myalgia Syndrome in 171 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 153 (89.47) | 18.2507 |
2000's | 11 (6.43) | 29.6817 |
2010's | 5 (2.92) | 24.3611 |
2020's | 2 (1.17) | 2.80 |
Authors | Studies |
---|---|
Baek, M; Heo, IK; Kim, YH; Lee, DH; Shin, Y | 1 |
Heo, IK; Kim, YH; Ko, SM; Park, JE; Shin, YU; Son, WC | 1 |
Boudreault, PL; Gagnon, H; Gleich, GJ; Klarskov, K; Marsault, E; Naylor, S; Normandin, C; Plancq, B | 1 |
Chatterjee, S; Langford, CA; Tamaki, H | 1 |
Kamb, ML; Love, LA; Miller, FW; Okada, S; Pandey, JP; Philen, RM | 1 |
Belohradsky, BH; Rieber, N | 1 |
Maitani, T; Saitoh, H | 1 |
Allen, JA; Hinchcliff, ME; Mahoney, JM; Miller, FW; Peterson, A; Sufit, R; Varga, J; Whitfield, ML; Wood, TA | 1 |
Fernstrom, JD | 1 |
Margolin, L | 1 |
Bagchi, D; Bagchi, M; Das, YT; Preuss, HG | 1 |
Garrett, RH; Smith, MJ | 1 |
Gordon, M; Lebwohl, M; Smith, E | 1 |
Martínez-Cabot, A; Messeguer, A | 1 |
Gomez-Reino, JJ; Jimenez, S; Kaufman, LD; Targoff, IN; Varga, J | 1 |
Falanga, V; Helfman, T; Murata, H; Ochoa, MS; Takagi, H; Zhou, L | 1 |
D'Arcy, PF | 1 |
Kaufman, LD; Kaufman, MA; Krupp, LB | 1 |
Clauw, DJ; Hertzman, PA; Kaufman, LD; Love, LA; Mease, PJ; Philen, RM; Pincus, T; Rosenberg, NL; Silver, R; Varga, J | 1 |
Berkson, L; Davis, W; Elmore, JG; Faith, JM; Haggerty, JL; Horwitz, RI; Laprise, R; Palmer, W; Spitzer, WO; Tamblyn, R | 1 |
Adachi, J; Gomez, M; Smith, CC; Sternberg, EM | 1 |
Gleich, GJ; Mayeno, AN | 2 |
Abrams, JS; Gleich, GJ; Goronzy, JJ; Kita, H; Lundy, SK; Mayeno, AN; Weiler, DA; Weyand, CM | 1 |
Adachi, J; Fujiwara, S; Mio, T; Naito, T; Nishimura, A; Sumino, K; Tatsuno, Y; Ueno, Y | 1 |
Sidransky, H | 1 |
Cabrera, GE; Cuellar, ML; Espinoza, CG; Espinoza, LR; Martinez-Osuna, P; Silveira, LH | 1 |
Ficco, A; Freundlich, B; Lanza, DC; Levine, B | 1 |
Manley, P; McKeon, P; Swanwick, G | 1 |
Shapiro, S | 3 |
Berger, F; De Saint Victor, JF; Mezin, P; Moreaud, O; Noelle, B; Pellat, J | 1 |
Berg, PA; Klein, R | 1 |
Emslie-Smith, AM; Engel, AG; Gleich, GJ; Mayeno, AN; Nakano, S | 1 |
Berg, PA; Carr, L; Lehnert, H; Rüther, E | 1 |
Arpino, C; Conti, F; Luan, FL; Priori, R; Valesini, G | 1 |
Sidransky, H; Verney, E | 1 |
Burns, SM; Hays, AP; Jaffe, I; Lange, DJ | 1 |
Fujita, K; Inuo, G; Kashiwazaki, S; Kolb, JP; Miyasaka, N; Saito, I; Yamaoka, KA | 1 |
Christophers, E; Gross, WL; Reusch, M; Schnabel, A | 1 |
Bingel, SA; Hampton, M; Harley, RA; Heyes, MP; Ludwicka, A; Maize, J; Ohba, T; Silver, RM; Smith, T | 1 |
Cosgrove, JW; Latham, PS; Mayeno, AN; Sidransky, H; Verney, E | 1 |
Goldman, LR; Hatch, DL | 1 |
Jimenez, SA; Li, L; Varga, J | 1 |
Dell'Isola, B; Labrousse, J; Lissac, J; Rezgui, N; Thiollieres, JM; Valcke, JC | 1 |
Kahn, MF; Labauge, P; Lessana-Leibowitch, M; Moulonguet, A; Penaud, D; Said, G | 1 |
Philen, RM; Posada, M | 1 |
Mitchell, N | 1 |
Bailey, SL; Caudill, SP; Driskell, WJ; Flanders, WD; Hill, RH; Kamb, ML; Needham, LL; Philen, RM; Sampson, EJ | 1 |
Avidor, R; Brenneman, DE; Burnet, P; Page, SW; Schultzberg, M; Sternberg, EM; Thomas, FS; Zelazowski, P | 1 |
Caudill, SP; Falk, H; Flanders, WD; Hill, RH; Kilbourne, EM; Needham, L; Philen, RM; Sampson, EJ; Sewell, L | 1 |
McNeil, JJ; Taylor, R | 1 |
Berry, CL | 1 |
Jimenez, SA; Uitto, J; Varga, J | 2 |
Colby, TV; Duffy, J; Myers, JL; Strickler, JG; Tazelaar, HD | 1 |
Auerbach, SB; de Oliveira, JS; Sale, GE; Sullivan, KM | 1 |
Meurer, M; Szeimies, RM | 1 |
Kaufman, LD; Philen, RM | 1 |
Friedman, SM; Henning, KJ; Hill, RH; Jean-Baptiste, E; Singh, T | 1 |
Jin, Z; Kurihara, N; Wada, O; Yanagisawa, H | 1 |
Beko, E; Dhawan, S; Nanda, V; Pervaiz, S | 1 |
Kaufman, LD; Krupp, LB; Masur, DM | 1 |
Back, EE; Brix, KA; Gunn, RA; Henning, KJ; Kallenbach, LR; Melius, JM | 1 |
Adachi, J; Naito, T; Ninomiya, I; Ogawa, Y; Tatsuno, Y; Ueno, Y | 1 |
Adachi, J; Ogawa, Y; Tatsuno, Y | 1 |
Hagiwara, Y; Kawase, Y; Sato, F | 1 |
Daniels, SR; Horwitz, RI; Hudson, JI | 1 |
Alexander, LR; Barnhart, ER; Gelbaum, LT; Hine, TK; Maggio, VL; Needham, LL; Reilly, MC; Turner, WE | 1 |
Falk, H; Jones, JL; Kamb, ML; Meyer, P; Philen, RM; Sinks, T; Sullivan, EA | 1 |
Mayeno, AN; Varga, J; Vining, V; Zangrilli, JG | 1 |
Falanga, V; Greenberg, AS; Hasan, A; Hill, RH; Murata, H; Takagi, H | 1 |
Bolster, M; Hampton, M; Ludwicka, A; Maize, J; Silver, R; Suzuki, S; Tourkina, E | 1 |
Hertzman, PA | 2 |
Belongia, EA; Gleich, GJ | 1 |
Philen, RM; Staehling, N; Sullivan, EA | 1 |
Clauw, DJ; Pincus, T | 1 |
Carter, WP; Daniels, SR; Hudson, JI; Pope, HG | 1 |
Daniels, SR; Horwitz, RI | 1 |
Berkson, L; Davis, W; Haggerty, JL; Laprise, R; Mulder, LJ; Palmer, W; Spitzer, WO; Tamblyn, R | 1 |
Falk, H; Kamb, ML; Kilbourne, EM; Philen, RM | 1 |
Clauw, DJ | 1 |
Miyamoto, T; Saito, H | 1 |
Sternberg, EM | 2 |
Latham, P; Schwartz, A; Sidransky, H; Verney, E | 1 |
Nicolodi, M; Sicuteri, F | 1 |
Adachi, J; Gomez, M; Smith, CC; Sternberg, EM; Tatsuno, Y; Ueno, Y | 1 |
Smith, SA | 1 |
Meyer, K; Simat, T; Steinhart, H; van Wickern, B | 1 |
Eulitz, K; Simat, T; Steinhart, EH; van Wickern, B | 1 |
Elmore, JG; Horwitz, RI; Wagner, KR | 1 |
Hisatomi, A; Imamura, T; Kubota, A; Nagata, T; Nawata, H; Ohashi, M; Umeda, F | 1 |
Hitraya, EG; Jimenez, SA; Ludwicka, A; Silver, RM; Varga, J | 1 |
Bankhurst, AD; Buss, WC; Mayeno, AN; Pastuszyn, A; Peabody, D; Stepanek, J | 1 |
Espinoza, LR | 1 |
Blackburn, WD | 1 |
Benson, LM; Gleich, GJ; Mayeno, AN; Naylor, S; Tomlinson, AJ; Williamson, BL | 1 |
Simat, T; Steinhart, H | 1 |
Gleich, GJ; Mishra, PK; Naylor, S; Tomlinson, AJ; Williamson, BL | 1 |
Weber, KT | 1 |
Gleich, GJ; Johnson, KL; Naylor, S; Tomlinson, AJ; Williamson, BL | 1 |
Böhme, A; Hoelzer, D; Wolter, M | 1 |
Gleich, GJ; Naylor, S | 1 |
Hori, H; Nakamura, J; Terao, T | 1 |
Benson, LM; Gleich, GJ; Johnson, KL; Klarskov, K; Naylor, S; Williamson, BL | 1 |
Gleich, GJ; Johnson, KL; Naylor, S; Williamson, BL | 1 |
Kleeberg, KK; Müller, B; Sierts, A; Simat, TJ | 1 |
Müller, B; Pacholski, C; Simat, T; Steinhart, H | 1 |
Barth, H; Berg, PA; Klein, R | 2 |
Kondo, H | 1 |
Higuchi, I; Niiyama, T | 1 |
Goto, K; Kumamoto, T | 1 |
Kilbourne, EM | 1 |
Jimenez, SA; Maul, GG; Varga, J | 1 |
Donofrio, PD; Ely, EW; Lefkowitz, DS; Miller, VS; Oestreich, L; Stanton, C; Walker, FO | 1 |
Heuschling, C | 1 |
Borysewicz, K; Szechiński, J | 1 |
Keating, JP; Viggiano, J; Wardill, K | 1 |
Golitz, LE; Guerin, SB; Kulik, JE; Schmidt, JJ | 1 |
Nightingale, SL | 1 |
Kashiwazaki, S; Kotake, S | 1 |
Bock, HG; Crawford, LV; Hill, RH; Philen, RM; Springer, MA | 1 |
Akahosi, T; Ishikawa, A; Kasiwazaki, S; Kondo, H; Okada, J | 1 |
Bornstein, RA; Kissel, JT; Lynn, J; Rammohan, KW | 1 |
Harati, Y; Heyes, MP; McKinley, K; Quearry, B; Silver, RM; Smith, EA; Sternberg, EM | 1 |
Goda, Y; Maitani, T; Suzuki, J; Takeda, M; Uchiyama, M; Yoshihira, K | 1 |
Belongia, EA; Gleich, GJ; Lin, F; Lundy, SK; Mayeno, AN | 1 |
Duffy, J | 2 |
Aldridge, WN | 1 |
Belongia, EA; Mayeno, AN; Osterholm, MT | 1 |
Ashley, DL; Driskell, WJ; Grainger, J; Hill, RH; Mazzola, EP; Needham, LL; Page, SW; Sirimanne, SR | 1 |
Mensing, H; Schallreuter, KU; Senff, H; Steinkraus, V | 1 |
Fleming, D; Hedberg, K; Matson, P; Slutsker, L; Urbach, D | 1 |
Carreira, P; Heyes, MP; Silver, RM; Sutherland, SE | 1 |
Chaudhry, V; Cornblath, DR; Freimer, ML; Glass, JD; Griffin, JW; Kuncl, RW; Tyor, WR | 1 |
Hibbs, JR; Hill, P; Medsger, TA; Mittleman, B | 1 |
Groves, RW; Hay, RJ; Koblar, S; Pitzalis, C; Simpson, KJ | 1 |
Bennert, KW; Cooper, GS; De Schryver-Kecskemeti, K; Yang, P | 1 |
Blanc, PD; Campagna, AC; Clarke, D; Criswell, LA; Gold, WM; Golden, JA; Sack, KE | 1 |
Clauw, D; Da Silva, AT; Katz, P; Read, CA; Weir, C | 1 |
Golbus, J; Neely, SE; Tanhehco, JL; Wiechers, DO | 1 |
Demisch, L; Zipp, F | 1 |
Fischer, G; Kröner, G; Neubrand, M; Sauerbruch, T; Scheurlen, C; Soehnchen, R | 1 |
Anderson, C; Swinbanks, D | 1 |
Roufs, JB | 1 |
André, M; Canon, JL; Dermine, P; Leveau, F; Levecque, P; Mortier, C | 1 |
Dangel, P; Hetzel, W; Molitor, H | 1 |
Fathi, M; Mainetti, C; Saurat, JH | 1 |
Caston, JC; Falk, H; Horney, LF; Jones, JL; Kamb, ML; Kilbourne, EM; Murphy, JJ; Nederlof, K; Swygert, LA | 1 |
Hefti, U; Steiger, U | 1 |
Milburn, DS; Myers, CW | 1 |
Chavaz, P; Mainetti, C; Masouyé, I; Saurat, JH; Schmied, E | 1 |
Cilursu, AM; Goeken, J; Olson, RR | 1 |
Kamatani, N | 1 |
Bournerias, I; Castot, A | 1 |
Cabane, J | 1 |
Bamford, CR; Tolander, LM | 1 |
Hashimoto, K; Kishida, M; Kuzuhara, S; Mizutani, H; Mizutani, T; Murata, M; Nakamura, Y; Shimizu, M; Taniguchi, H | 1 |
Bochner, BS; Friedman, B; Krishnaswami, G; Kroegel, C; Lichtenstein, LM; Schleimer, RP | 1 |
Aldhous, P | 1 |
Adachi, J; Mizoi, Y; Ogawa, Y; Tatsuno, Y; Ueno, Y; Yamamoto, K | 1 |
Gleason, CB; Marchman, HB; Shaw, JC | 1 |
Ebisawa, H; Oguro, K; Sato, F; Shishikura, T; Tsuchiya, T | 1 |
Brousse, P; Danel, V; Hardelin, D; Mallaret, M; Saviuc, P | 1 |
James, TN | 1 |
40 review(s) available for tryptophan and Eosinophilia-Myalgia Syndrome
Article | Year |
---|---|
Safety concerns regarding impurities in L-Tryptophan associated with eosinophilia myalgia syndrome.
Topics: Animals; Dietary Supplements; Eosinophilia-Myalgia Syndrome; Humans; Muscles; Tryptophan | 2023 |
Eosinophilia in Rheumatologic/Vascular Disorders.
Topics: Arthritis, Rheumatoid; Churg-Strauss Syndrome; Eosinophilia; Eosinophilia-Myalgia Syndrome; Eosinophils; Fasciitis; Humans; Muscular Dystrophies, Limb-Girdle; Tryptophan | 2015 |
[Eosinophilia myalgia syndrome (EMS) caused by L-tryptophan product and toxic oil syndrome (TOS) caused by denatured rape-seed oil].
Topics: Aniline Compounds; Animals; Disease Outbreaks; Eosinophilia-Myalgia Syndrome; Fatty Acids, Monounsaturated; Female; Food Contamination; Humans; Male; Plant Oils; Propylene Glycols; Rapeseed Oil; Syndrome; Time Factors; Tryptophan | 2009 |
Effects and side effects associated with the non-nutritional use of tryptophan by humans.
Topics: Affect; Dietary Supplements; Eosinophilia-Myalgia Syndrome; Humans; Serotonin; Sleep; Tryptophan | 2012 |
Safety of 5-hydroxy-L-tryptophan.
Topics: 5-Hydroxytryptophan; Adult; Animals; Antidepressive Agents; Depressive Disorder; Drug Contamination; Eosinophilia-Myalgia Syndrome; Female; Humans; Legislation, Drug; Nonprescription Drugs; Tryptophan; United States; United States Food and Drug Administration | 2004 |
A heretofore undisclosed crux of eosinophilia-myalgia syndrome: compromised histamine degradation.
Topics: Amino Acids; Animals; Eosinophilia-Myalgia Syndrome; Histamine; Humans; Hypothalamo-Hypophyseal System; Indoles; Mast Cells; Serotonin; Tryptophan | 2005 |
L-tryptophan: eosinophilia-myalgia syndrome.
Topics: Drug Contamination; Eosinophilia-Myalgia Syndrome; Humans; Tryptophan; United Kingdom | 1995 |
The eosinophilia-myalgia syndrome--guidelines for patient care.
Topics: Anxiety; Depression; Eosinophilia-Myalgia Syndrome; Glucocorticoids; Heart Diseases; Humans; Lung Diseases; Mental Processes; Neuromuscular Diseases; Practice Guidelines as Topic; Psychotherapy; Skin Diseases; Tryptophan | 1995 |
Eosinophilia-myalgia syndrome: a recent syndrome serving as an alert to new diseases ahead.
Topics: Animals; Eosinophilia-Myalgia Syndrome; Humans; Rats; Tryptophan | 1994 |
Head and neck manifestations of eosinophilia-myalgia syndrome.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Combined Modality Therapy; Drug Therapy, Combination; Eosinophilia-Myalgia Syndrome; Female; Humans; Incidence; Male; Medical History Taking; Middle Aged; Otorhinolaryngologic Diseases; Sex Factors; Surgical Procedures, Operative; Surveys and Questionnaires; Tryptophan | 1995 |
[Demyelinating nervous lesions in myalgia-eosinophilia syndrome induced by L Tryptophan].
Topics: Demyelinating Diseases; Eosinophilia-Myalgia Syndrome; Female; Humans; Middle Aged; Peripheral Nervous System Diseases; Tryptophan | 1993 |
Toxic oil syndrome and eosinophilia-myalgia syndrome: May 8-10, 1991, World Health Organization meeting report.
Topics: Animals; Brassica; Drug Contamination; Eosinophilia-Myalgia Syndrome; Fatty Acids, Monounsaturated; Food Contamination; Humans; Incidence; Plant Oils; Rapeseed Oil; Syndrome; Tryptophan; World Health Organization | 1993 |
L-tryptophan and the eosinophilia-myalgia syndrome: current understanding of the etiology and pathogenesis.
Topics: Animals; Autoimmunity; Drug Contamination; Eosinophilia-Myalgia Syndrome; Eosinophils; Fibrosis; Humans; Tryptophan | 1993 |
Tryptophan. Current status and future trends for oral administration.
Topics: Administration, Oral; Eosinophilia-Myalgia Syndrome; Humans; Tryptophan | 1993 |
Long-term follow-up of patients with diffuse fasciitis and eosinophilia associated with L-tryptophan ingestion.
Topics: Adult; Aged; Eosinophilia; Eosinophilia-Myalgia Syndrome; Fasciitis; Female; Follow-Up Studies; Humans; Tryptophan | 1993 |
Epidemiology of potential association between L-tryptophan ingestion and eosinophilia-myalgia syndrome.
Topics: Case-Control Studies; Confounding Factors, Epidemiologic; Eosinophilia-Myalgia Syndrome; Epidemiologic Methods; Humans; Selection Bias; Tryptophan; United States | 1995 |
The eosinophilia-myalgia syndrome: what we know, what we think we know, and what we need to know.
Topics: Centers for Disease Control and Prevention, U.S.; Congresses as Topic; Disease Models, Animal; Eosinophilia-Myalgia Syndrome; Humans; Population Surveillance; Tryptophan; United States | 1996 |
Tryptophan produced by Showa Denko and epidemic eosinophilia-myalgia syndrome.
Topics: Drug Industry; Eosinophilia-Myalgia Syndrome; Humans; Tryptophan | 1996 |
Animal models of the eosinophilia-myalgia syndrome.
Topics: Animals; Disease Models, Animal; Eosinophilia-Myalgia Syndrome; Macaca mulatta; Mice; Rats; Tryptophan | 1996 |
Pathogenesis of L-tryptophan eosinophilia myalgia syndrome.
Topics: 5-Hydroxytryptophan; Animals; Eosinophilia; Eosinophilia-Myalgia Syndrome; Eosinophils; Humans; Tryptophan | 1996 |
The eosinophilia-myalgia syndrome and the toxic oil syndrome. Pursuing parallels.
Topics: Brassica; Connective Tissue Diseases; Eosinophilia; Eosinophilia-Myalgia Syndrome; Fatty Acids, Monounsaturated; Humans; Plant Oils; Poisoning; Rapeseed Oil; Spain; Syndrome; Tryptophan; United States | 1996 |
Effects of tryptophan related compounds on nuclear regulatory control. Possible role in the eosinophilia-myalgia syndrome.
Topics: Alanine; Animals; Drug Contamination; Eosinophilia-Myalgia Syndrome; Humans; Liver; Nuclear Envelope; Proteins; Receptors, Cytoplasmic and Nuclear; RNA; Tryptophan | 1996 |
The eosinophilia myalgia syndrome: to be or not to be.
Topics: Eosinophilia-Myalgia Syndrome; Humans; Tryptophan | 1997 |
Eosinophilia myalgia syndrome.
Topics: Diagnosis, Differential; Eosinophilia-Myalgia Syndrome; Humans; Tryptophan | 1997 |
[L-tryptophan-induced eosinophilia-myalgia syndrome, Chinese restaurant syndrome].
Topics: Chest Pain; Eosinophilia-Myalgia Syndrome; Fatigue; Food Additives; Headache; Hot Flashes; Humans; Prognosis; Sodium Glutamate; Syndrome; Tryptophan | 1999 |
[Scleroderma, scleroderma related diseases].
Topics: Aniline Compounds; Animals; Bleomycin; Carbidopa; Diagnosis, Differential; Eosinophilia-Myalgia Syndrome; Epoxy Resins; Humans; Occupational Exposure; Polyvinyl Chloride; Prognosis; Scleroderma, Systemic; Silicon Dioxide; Silicones; Solvents; Tryptophan | 2000 |
[Eosinophilia myalgia syndrome, toxic oil syndrome].
Topics: Aniline Compounds; Anti-Inflammatory Agents; Antidepressive Agents, Second-Generation; Diagnosis, Differential; Dietary Fats, Unsaturated; Eosinophilia-Myalgia Syndrome; Food Contamination; Humans; Prognosis; Steroids; Tryptophan | 2001 |
[Fasciitis, perimyositis, microangiopathy].
Topics: Diagnosis, Differential; Eosinophilia-Myalgia Syndrome; Fasciitis; Fatty Acids, Monounsaturated; Food Contamination; Humans; Myositis; Peripheral Vascular Diseases; Plant Oils; Pneumonia; Prognosis; Propylene Glycols; Rapeseed Oil; Syndrome; Tryptophan | 2001 |
[Eosinophilia-myalgia syndrome].
Topics: Combined Modality Therapy; Eosinophilia-Myalgia Syndrome; Humans; Prognosis; Tryptophan | 1992 |
The toxic oil syndrome (TOS, 1981): from the disease towards a toxicological understanding of its chemical aetiology and mechanism.
Topics: Adolescent; Adult; Aged; Aniline Compounds; Animals; Cause of Death; Eosinophilia-Myalgia Syndrome; Fatty Acids, Monounsaturated; Female; Food Contamination; Humans; Male; Middle Aged; Plant Oils; Rapeseed Oil; Rats; Syndrome; Tryptophan | 1992 |
The eosinophilia-myalgia syndrome and tryptophan.
Topics: Animals; Eosinophilia-Myalgia Syndrome; Humans; Risk Factors; Tryptophan | 1992 |
The lessons of eosinophilia-myalgia syndrome.
Topics: Adult; Diagnosis, Differential; Drug Contamination; Eosinophilia-Myalgia Syndrome; Female; Humans; Nonprescription Drugs; Tryptophan | 1992 |
[Current aspects in discussion of eosinophilia-myalgia syndrome].
Topics: Diagnosis, Differential; Eosinophilia-Myalgia Syndrome; Humans; Neurologic Examination; Tryptophan | 1992 |
Review of L-tryptophan and eosinophilia-myalgia syndrome.
Topics: Animals; Eosinophilia-Myalgia Syndrome; Female; Humans; Male; Tryptophan | 1992 |
Eosinophilia-myalgia syndrome associated with L-tryptophan. A case report with pulmonary manifestations and review of the literature.
Topics: Eosinophilia-Myalgia Syndrome; Female; Humans; Methylprednisolone; Middle Aged; Pleural Effusion; Tryptophan | 1991 |
The cause and pathogenesis of the eosinophilia-myalgia syndrome.
Topics: Drug Contamination; Eosinophilia-Myalgia Syndrome; Eosinophils; Humans; Tryptophan | 1992 |
Tryptophan toxicity: a pharmacoepidemiologic review of eosinophilia-myalgia syndrome.
Topics: Eosinophilia-Myalgia Syndrome; Humans; Tryptophan; United States | 1991 |
[Scleroderma and environment. III. Eosinophilia-myalgia syndrome and L-tryptophan].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Dermatomyositis; Diagnosis, Differential; Eosinophilia-Myalgia Syndrome; Female; Humans; Middle Aged; Tryptophan | 1991 |
[Myalgia-eosinophilia syndrome. Tryptophan disease].
Topics: Eosinophilia-Myalgia Syndrome; Humans; Tryptophan | 1991 |
L-tryptophan and the eosinophilia-myalgia syndrome.
Topics: Eosinophilia-Myalgia Syndrome; Humans; Tryptophan; United Kingdom; United States | 1990 |
2 trial(s) available for tryptophan and Eosinophilia-Myalgia Syndrome
Article | Year |
---|---|
A comparative study on antibodies to nucleoli and 5-hydroxytryptamine in patients with fibromyalgia syndrome and tryptophan-induced eosinophilia-myalgia syndrome.
Topics: Acute Disease; Adult; Aged; Antibodies, Antiphospholipid; Autoantibodies; Blotting, Western; Cell Nucleolus; Chronic Disease; Eosinophilia-Myalgia Syndrome; Female; Fibromyalgia; Follow-Up Studies; G(M1) Ganglioside; Humans; Male; Middle Aged; Serotonin; Tryptophan | 1994 |
Epidemiology of potential association between L-tryptophan ingestion and eosinophilia-myalgia syndrome.
Topics: Case-Control Studies; Confounding Factors, Epidemiologic; Eosinophilia-Myalgia Syndrome; Epidemiologic Methods; Humans; Selection Bias; Tryptophan; United States | 1995 |
130 other study(ies) available for tryptophan and Eosinophilia-Myalgia Syndrome
Article | Year |
---|---|
Simultaneous determination of L-tryptophan impurities in meat products.
Topics: Animals; Chromatography, High Pressure Liquid; Chromatography, Liquid; Eosinophilia-Myalgia Syndrome; Humans; Meat Products; Swine; Tandem Mass Spectrometry; Tryptophan | 2023 |
Structure determination of disease associated peak AAA from l-Tryptophan implicated in the eosinophilia-myalgia syndrome.
Topics: Chromatography, High Pressure Liquid; Dietary Supplements; Drug Contamination; Eosinophilia-Myalgia Syndrome; Humans; Mass Spectrometry; Tandem Mass Spectrometry; Tryptophan | 2018 |
Immunogenetic risk and protective factors for the development of L-tryptophan-associated eosinophilia-myalgia syndrome and associated symptoms.
Topics: Adult; Disease Outbreaks; Eosinophilia-Myalgia Syndrome; Female; Genetic Predisposition to Disease; HLA-DQ alpha-Chains; HLA-DQ Antigens; HLA-DR Antigens; HLA-DRB1 Chains; Humans; Immunoglobulin Gm Allotypes; Immunoglobulin Km Allotypes; Male; Middle Aged; Molecular Epidemiology; Risk Factors; Tryptophan | 2009 |
AHR activation by tryptophan--pathogenic hallmark of Th17-mediated inflammation in eosinophilic fasciitis, eosinophilia-myalgia-syndrome and toxic oil syndrome?
Topics: Brassica; Eosinophilia; Eosinophilia-Myalgia Syndrome; Fasciitis; Fatty Acids, Monounsaturated; Humans; Inflammation; Interleukin-17; Plant Oils; Rapeseed Oil; Receptors, Aryl Hydrocarbon; Syndrome; T-Lymphocytes, Helper-Inducer; Tryptophan | 2010 |
Post-epidemic eosinophilia-myalgia syndrome associated with L-tryptophan.
Topics: Adult; Eosinophilia-Myalgia Syndrome; Female; Humans; Tryptophan | 2011 |
Non-L-tryptophan related eosinophilia-myalgia syndrome with hypoproteinemia and hypoalbuminemia.
Topics: Anti-Inflammatory Agents; Edema; Eosinophilia-Myalgia Syndrome; Female; Humans; Hypoalbuminemia; Middle Aged; Prednisone; Tryptophan | 2003 |
Calcinosis cutis in a patient with eosinophilia-myalgia syndrome: case report.
Topics: Aged; Antidepressive Agents, Second-Generation; Calcinosis; Eosinophilia-Myalgia Syndrome; Female; Humans; Radiography; Skin Diseases; Tryptophan | 2006 |
Generation of quinoneimine intermediates in the bioactivation of 3-(N-phenylamino)alanine (PAA) by human liver microsomes: a potential link between eosinophilia-myalgia syndrome and toxic oil syndrome.
Topics: Alanine; Biotransformation; Chromatography, High Pressure Liquid; Disease Outbreaks; Eosinophilia-Myalgia Syndrome; Fatty Acids, Monounsaturated; Food Contamination; Foodborne Diseases; Humans; Microsomes, Liver; Plant Oils; Quinones; Rapeseed Oil; Spain; Spectrometry, Mass, Electrospray Ionization; Tryptophan | 2007 |
Autoantibodies in sera from patients with L-tryptophan-associated eosinophilia-myalgia syndrome. Demonstration of unique antigen-antibody specificities.
Topics: Autoantibodies; Eosinophilia; Eosinophilia-Myalgia Syndrome; Epitopes; Fasciitis; Humans; Oils; Precipitin Tests; Tryptophan | 1995 |
Enhanced collagen synthesis and transcription by peak E, a contaminant of L-tryptophan preparations associated with the eosinophilia myalgia syndrome epidemic.
Topics: Cells, Cultured; Collagen; DNA Replication; Drug Contamination; Eosinophilia-Myalgia Syndrome; Fibroblasts; Humans; Skin; Transcription, Genetic; Tryptophan | 1995 |
Movement disorders in the eosinophilia-myalgia syndrome: tremor, myoclonus, and myokymia.
Topics: Adult; Cohort Studies; Electromyography; Eosinophilia-Myalgia Syndrome; Fasciculation; Female; Humans; Male; Middle Aged; Myoclonus; Tremor; Tryptophan | 1995 |
Continuing occurrence of eosinophilia myalgia syndrome in Canada.
Topics: Adult; Aged; Environmental Monitoring; Eosinophilia-Myalgia Syndrome; Epidemiological Monitoring; Female; Humans; Male; Middle Aged; Ontario; Quebec; Tryptophan | 1995 |
Accumulation of 3-(phenylamino)alanine, a constituent in L-tryptophan products implicated in eosinophilia-myalgia syndrome, in blood and organs of the Lewis rats.
Topics: Alanine; Animals; Chromatography, High Pressure Liquid; Drug Contamination; Drug Residues; Eosinophilia-Myalgia Syndrome; Female; Rats; Rats, Inbred Lew; Tissue Distribution; Tryptophan | 1995 |
Eosinophilia-myalgia syndrome and tryptophan production: a cautionary tale.
Topics: Animals; Brassica; Chemical Industry; Disease Models, Animal; Disease Outbreaks; Drug Contamination; Eosinophilia-Myalgia Syndrome; Fatty Acids, Monounsaturated; Humans; Mice; Mice, Inbred C57BL; Plant Oils; Population Surveillance; Rapeseed Oil; Risk Factors; Tryptophan | 1994 |
Eosinophil-active cytokine from mononuclear cells cultured with L-tryptophan products: an unexpected consequence of endotoxin contamination.
Topics: Cell Survival; Cells, Cultured; Cytokines; Endotoxins; Eosinophilia-Myalgia Syndrome; Eosinophils; Humans; Leukocytes, Mononuclear; Tryptophan | 1995 |
Identification of four metabolites of 3-(phenylamino)alanine, a constituent in L-tryptophan products implicated in eosinophilia-myalgia syndrome, in rats.
Topics: Administration, Oral; Alanine; Animals; Blood-Brain Barrier; Brain; Chromatography, High Pressure Liquid; Drug Contamination; Eosinophilia-Myalgia Syndrome; Gas Chromatography-Mass Spectrometry; Kidney; Liver; Lung; Male; Phenylalanine; Rats; Rats, Wistar; Structure-Activity Relationship; Tissue Distribution; Tryptophan | 1994 |
Eosinophilic hepatitis: a new feature of the clinical spectrum of the eosinophilia-myalgia syndrome.
Topics: Adult; Biopsy, Needle; Bone Marrow; Chemical and Drug Induced Liver Injury; Eosinophilia-Myalgia Syndrome; Female; Hematologic Tests; Humans; Liver; Liver Function Tests; Tryptophan | 1994 |
L-tryptophan and the eosinophilia-myalgia syndrome: a clinical and laboratory study.
Topics: Antibodies, Antinuclear; Antidepressive Agents; Ascorbic Acid; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Eosinophilia-Myalgia Syndrome; Eosinophils; Female; Fructose-Bisphosphate Aldolase; Humans; Leukocyte Count; Male; Pyridoxine; Tryptophan | 1994 |
L-tryptophan and eosinophilia-myalgia syndrome.
Topics: Case-Control Studies; Eosinophilia-Myalgia Syndrome; Humans; New Mexico; Tryptophan | 1994 |
L-tryptophan and eosinophilia-myalgia syndrome.
Topics: Case-Control Studies; Eosinophilia-Myalgia Syndrome; Humans; Tryptophan | 1994 |
[Peripheral neuropathy unmasked by therapy with adrenal cortex hormones during myalgia-eosinophilia syndrome related to L-tryptophan].
Topics: Adult; Eosinophilia-Myalgia Syndrome; Female; Humans; Immunoglobulins, Intravenous; Peripheral Nervous System Diseases; Prednisone; Tryptophan | 1994 |
1,1'-Ethylidenebis[tryptophan] induces pathologic alterations in muscle similar to those observed in the eosinophilia-myalgia syndrome.
Topics: Animals; Eosinophilia-Myalgia Syndrome; Female; Macrophages; Microcirculation; Muscles; Rats; Rats, Inbred Lew; Time Factors; Tryptophan | 1994 |
Eosinophilia-myalgia syndrome in Germany: an epidemiologic review.
Topics: Adult; Aged; Aged, 80 and over; Drug Contamination; Drug Prescriptions; Eosinophilia-Myalgia Syndrome; Female; Germany; Humans; Incidence; Male; Middle Aged; Self Administration; Tryptophan; United States | 1994 |
The eosinophilia-myalgia syndrome: lessons from Germany.
Topics: Animals; Disease Outbreaks; Drug Contamination; Eosinophilia-Myalgia Syndrome; Female; Germany; Humans; Tryptophan; United States | 1994 |
Chronic fatigue: a peculiar evolution of eosinophilia myalgia syndrome following treatment with L-tryptophan in four Italian adolescents.
Topics: Adolescent; Eosinophilia-Myalgia Syndrome; Fatigue Syndrome, Chronic; Female; Humans; Italy; Male; Tryptophan | 1994 |
Comparative studies on tryptophan binding to hepatic nuclear envelopes in Sprague-Dawley and Lewis rats.
Topics: Animals; Binding, Competitive; Cell Nucleus; Drug Compounding; Eosinophilia-Myalgia Syndrome; Fasting; Female; Japan; Liver; Nuclear Envelope; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Tryptophan; Tryptophan Oxygenase | 1994 |
Axonal neuropathy in eosinophilia-myalgia syndrome.
Topics: Axons; Eosinophilia-Myalgia Syndrome; Female; Humans; Male; Middle Aged; Muscles; Peripheral Nervous System Diseases; Tryptophan | 1994 |
1,1'-Ethylidenebis(tryptophan) (Peak E) induces functional activation of human eosinophils and interleukin 5 production from T lymphocytes: association of eosinophilia-myalgia syndrome with a L-tryptophan contaminant.
Topics: B-Lymphocytes; Base Sequence; Blood Proteins; Electrophoresis, Agar Gel; Eosinophil Granule Proteins; Eosinophilia-Myalgia Syndrome; Eosinophils; Humans; Interleukin-5; Lymphocyte Activation; Molecular Sequence Data; Polymerase Chain Reaction; Receptors, Interleukin; Receptors, Interleukin-5; Ribonucleases; RNA, Messenger; Spleen; T-Lymphocytes; Tryptophan; Tumor Cells, Cultured | 1994 |
[Eosinophilic fasciitis (Shulman syndrome). Differential diagnosis of chronic eosinophilia-myalgia syndrome after L-tryptophan administration].
Topics: Adipose Tissue; Biopsy; Connective Tissue; Diagnosis, Differential; Eosinophilia; Eosinophilia-Myalgia Syndrome; Fascia; Fasciitis; Follow-Up Studies; Humans; Male; Middle Aged; Skin; Tryptophan | 1994 |
A murine model of the eosinophilia-myalgia syndrome induced by 1,1'-ethylidenebis (L-tryptophan).
Topics: Animals; Disease Models, Animal; Eosinophilia-Myalgia Syndrome; Fascia; Female; Mice; Mice, Inbred C57BL; Muscles; Quinolinic Acid; Tryptophan | 1994 |
Studies with 1,1'-ethylidenebis(tryptophan), a contaminant associated with L-tryptophan implicated in the eosinophilia-myalgia syndrome.
Topics: Animals; Eosinophilia-Myalgia Syndrome; Female; In Vitro Techniques; Liver; Nuclear Envelope; Proteins; Rats; Rats, Sprague-Dawley; Tritium; Tryptophan | 1994 |
Reduced severity of eosinophilia-myalgia syndrome associated with the consumption of vitamin-containing supplements before illness.
Topics: Adult; Age Factors; Aged; California; Case-Control Studies; Eosinophilia-Myalgia Syndrome; Female; Humans; Male; Medical History Taking; Middle Aged; Sex Factors; Tryptophan; Vitamins | 1993 |
Increased type I collagen gene expression in L-tryptophan associated eosinophilia-myalgia syndrome skin fibroblasts.
Topics: Adult; Cells, Cultured; Collagen; Eosinophilia-Myalgia Syndrome; Female; Fibroblasts; Gene Expression; Homeostasis; Humans; Interferon-gamma; Male; Middle Aged; Procollagen; RNA, Messenger; Skin; Tryptophan | 1993 |
[Acute pleuropericarditis with eosinophilia after ingestion of tryptophan].
Topics: Acute Disease; Adult; Eosinophilia-Myalgia Syndrome; Humans; Male; Pericarditis; Pleurisy; Tryptophan | 1993 |
L-tryptophan and eosinophilia-myalgia syndrome.
Topics: Australia; Eosinophilia-Myalgia Syndrome; Humans; Medication Systems; Tryptophan | 1993 |
Contaminants in L-tryptophan associated with eosinophilia myalgia syndrome.
Topics: Bacillus; Drug Contamination; Eosinophilia-Myalgia Syndrome; Humans; South Carolina; Tryptophan | 1993 |
A decomposition product of a contaminant implicated in L-tryptophan eosinophilia myalgia syndrome affects spinal cord neuronal cell death and survival through stereospecific, maturation and partly interleukin-1-dependent mechanisms.
Topics: Animals; Carbolines; Cell Death; Cell Survival; Cells, Cultured; Drug Contamination; Eosinophilia-Myalgia Syndrome; Female; Interleukin-1; Mice; Pregnancy; Receptors, Interleukin-1; Recombinant Proteins; Spinal Cord; Stereoisomerism; Tryptophan | 1993 |
Tryptophan contaminants associated with eosinophilia-myalgia syndrome. The Eosinophilia-Myalgia Studies of Oregon, New York and New Mexico.
Topics: Drug Contamination; Eosinophilia-Myalgia Syndrome; Humans; Tryptophan | 1993 |
Eosinophilia-myalgia syndrome: lessons for public health researchers.
Topics: Australia; Case-Control Studies; Centers for Disease Control and Prevention, U.S.; Disease Models, Animal; Disease Outbreaks; Drug Industry; Eosinophilia-Myalgia Syndrome; Epidemiologic Methods; Humans; Information Services; Public Health; Research; Tryptophan; United States | 1993 |
Of faddism, toxic oil, and scleroderma.
Topics: Adult; Brassica; Diet Fads; Eosinophilia-Myalgia Syndrome; Fatty Acids, Monounsaturated; Female; Humans; Middle Aged; Plant Oils; Rapeseed Oil; Scleroderma, Systemic; Tryptophan | 1993 |
Tryptophan-induced lung disease: an immunophenotypic, immunofluorescent, and electron microscopic study.
Topics: Adult; Eosinophilia-Myalgia Syndrome; Female; Fluorescent Antibody Technique; Humans; Immunophenotyping; Lung Diseases; Microscopy, Electron; T-Lymphocytes; Tryptophan | 1993 |
Fatal eosinophilia myalgia syndrome in a marrow transplant patient attributed to total parenteral nutrition with a solution containing tryptophan.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Eosinophilia-Myalgia Syndrome; Humans; Male; Parenteral Nutrition, Total; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Solutions; Tryptophan | 1993 |
[The tryptophan-associated eosinophilia-myalgia syndrome. A clinical follow-up of 8 patients].
Topics: Aged; Biopsy; Drug Therapy, Combination; Eosinophilia-Myalgia Syndrome; Female; Follow-Up Studies; Humans; Male; Middle Aged; Muscles; Myxedema; Scleroderma, Systemic; Skin; Tryptophan | 1993 |
Eosinophilia-myalgia syndrome in patients ingesting a single source of L-tryptophan.
Topics: Case-Control Studies; Chromium; Dose-Response Relationship, Drug; Drug Interactions; Eosinophilia-Myalgia Syndrome; Female; Humans; Male; Middle Aged; Multivariate Analysis; New York City; Pyridoxine; Risk Factors; Tryptophan | 1993 |
Production of polyclonal antibodies against 1,1'-ethyliden bis[L-tryptophan] (EBT), a potential contaminant causing eosinophilia-myalgia syndrome (EMS).
Topics: Animals; Antibody Formation; Binding Sites; Eosinophilia-Myalgia Syndrome; Immunization; Male; Molecular Weight; Rabbits; Serum Albumin, Bovine; Spectrophotometry, Ultraviolet; Tryptophan | 1993 |
Neurocognitive dysfunction in the eosinophilia-myalgia syndrome.
Topics: Attention; Cognition Disorders; Drug Contamination; Eosinophilia-Myalgia Syndrome; Female; Humans; Male; Memory; Middle Aged; Motor Activity; Psychological Tests; Tryptophan | 1993 |
Risk factors for developing eosinophilia myalgia syndrome among L-tryptophan users in New York.
Topics: Adolescent; Adult; Case-Control Studies; Child, Preschool; Dose-Response Relationship, Drug; Drug Industry; Eosinophilia-Myalgia Syndrome; Female; Humans; Male; New York; Regression Analysis; Risk Factors; Tryptophan | 1993 |
Metabolism and distribution in the rat of peak E substance, a constituent in L-tryptophan product implicated in eosinophilia-myalgia syndrome.
Topics: Animals; Carbolines; Chromatography, High Pressure Liquid; Drug Contamination; Eosinophilia-Myalgia Syndrome; Male; Rats; Rats, Wistar; Tryptophan | 1993 |
Accumulation of 1-methyl-tetrahydro-beta-carboline-3-carboxylic acid in blood and organs of rat. A possible causative substance of eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan.
Topics: Animals; Carbolines; Eosinophilia-Myalgia Syndrome; Male; Rats; Rats, Wistar; Tissue Distribution; Tryptophan | 1993 |
Subchronic toxicity of 3-phenylamino alanine, an impurity in L-tryptophan reported to be associated with eosinophilia-myalgia syndrome.
Topics: Administration, Oral; Alanine; Animals; Blood Chemical Analysis; Brain; Chromatography, High Pressure Liquid; Disease Models, Animal; Eosinophilia-Myalgia Syndrome; Female; Heart; Kidney; Liver; Macrophages, Alveolar; Male; Organ Size; Random Allocation; Rats; Rats, Sprague-Dawley; Testis; Tissue Distribution; Tryptophan | 1995 |
Analytical characterization of peptide contaminants of L-tryptophan.
Topics: Amino Acids; Anti-Bacterial Agents; Bacillus; Bacitracin; Chromatography, High Pressure Liquid; Drug Contamination; Eosinophilia-Myalgia Syndrome; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Spectrometry, Mass, Fast Atom Bombardment; Tryptophan | 1996 |
The natural history of eosinophilia-myalgia syndrome in a tryptophan-exposed cohort in South Carolina.
Topics: Drug Contamination; Eosinophilia-Myalgia Syndrome; Female; Follow-Up Studies; Humans; Male; Middle Aged; Tryptophan | 1996 |
1,1'-Ethylidenebis[L-tryptophan], an impurity in L-tryptophan associated with eosinophilia-myalgia syndrome, stimulates type I collagen gene expression in human fibroblasts in vitro.
Topics: Carbolines; Cell Division; Cells, Cultured; Collagen; Eosinophilia-Myalgia Syndrome; Extracellular Matrix; Fibroblasts; Gene Expression Regulation; Humans; Stimulation, Chemical; Tryptophan | 1995 |
Delayed onset of skin fibrosis after the ingestion of eosinophilia-myalgia syndrome-associated L-tryptophan.
Topics: Adult; Eosinophilia-Myalgia Syndrome; Female; Fibrosis; Hand Dermatoses; Humans; Leg Dermatoses; Skin; Tryptophan | 1996 |
A contaminant of L-tryptophan enhances expression of dermal collagen in a murine model of eosinophilia myalgia syndrome.
Topics: Animals; Blotting, Northern; Collagen; Disease Models, Animal; Eosinophilia-Myalgia Syndrome; Female; In Situ Hybridization; Mice; Mice, Inbred C57BL; RNA, Messenger; Tryptophan | 1996 |
The eosinophilia-myalgia syndrome: opportunities realized and missed.
Topics: Clinical Trials as Topic; Eosinophilia-Myalgia Syndrome; Humans; Tryptophan | 1996 |
The eosinophilia-myalgia syndrome revisited.
Topics: Case-Control Studies; Eosinophilia-Myalgia Syndrome; History, 20th Century; Humans; Tryptophan | 1996 |
Eosinophilia-myalgia syndrome among the non-L-tryptophan users and pre-epidemic cases.
Topics: Adult; Age Factors; Disease Outbreaks; Eosinophilia-Myalgia Syndrome; Female; Humans; Male; Middle Aged; Sex Factors; Tryptophan | 1996 |
Fibromyalgia, psychiatric disorders, and assessment of the longterm outcome of eosinophilia-myalgia syndrome.
Topics: Adult; Diagnosis, Differential; Eosinophilia-Myalgia Syndrome; Female; Fibromyalgia; Humans; Longitudinal Studies; Mental Disorders; Middle Aged; Tryptophan | 1996 |
Epidemiologic studies of the association of L-tryptophan with the eosinophilia-myalgia syndrome: a critique.
Topics: Case-Control Studies; Drug Contamination; Eosinophilia; Eosinophilia-Myalgia Syndrome; Epidemiologic Methods; Fasciitis; Humans; Tryptophan | 1996 |
Bias or biology: evaluating the epidemiologic studies of L-tryptophan and the eosinophilia-myalgia syndrome.
Topics: Case-Control Studies; Eosinophilia-Myalgia Syndrome; Epidemiologic Methods; Humans; Observer Variation; Research Design; Tryptophan | 1996 |
Analysis of Centers for Disease Control and Prevention criteria for the eosinophilia-myalgia syndrome in a geographically defined population.
Topics: Adult; Centers for Disease Control and Prevention, U.S.; Eosinophilia-Myalgia Syndrome; Female; Humans; Male; Middle Aged; Ontario; Patient Selection; Prevalence; Quebec; Tryptophan; United States | 1996 |
Effect of L-tryptophan products on function of human eosinophils: investigation of the causal mechanisms of eosinophilia myalgia syndrome associated with L-tryptophan products.
Topics: Cell Adhesion; Chemotaxis, Leukocyte; Eosinophilia-Myalgia Syndrome; Gene Expression; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Intercellular Adhesion Molecule-1; Interleukin-8; RNA, Messenger; Time Factors; Tryptophan; Vascular Cell Adhesion Molecule-1 | 1996 |
Eosinophilia myalgia syndrome. The role of contaminants, the role of serotonergic metabolism set up.
Topics: Drug Contamination; Eosinophilia-Myalgia Syndrome; Female; Fenclonine; Fever; Humans; Male; Migraine Disorders; Pain; Receptors, Serotonin; Retrospective Studies; Serotonin; Serotonin Agents; Tryptophan | 1996 |
A comparative study of tissue distribution and excretion among three substances implicated in eosinophilia-myalgia syndrome.
Topics: Alanine; Animals; Biotransformation; Brain; Carbolines; Eosinophilia-Myalgia Syndrome; Humans; Kidney; Liver; Rats; Tissue Distribution; Tryptophan | 1996 |
Persistent microvasculopathy in chronic eosinophilia-myalgia syndrome.
Topics: Arterioles; Biopsy; Capillaries; Drug Contamination; Endothelium, Vascular; Eosinophilia-Myalgia Syndrome; Follow-Up Studies; Humans; Microscopy, Electron; Muscle, Skeletal; Muscle, Smooth, Vascular; Necrosis; Skin; Time Factors; Tryptophan | 1996 |
Synthesis and analysis of contaminants in ems-related tryptophan.
Topics: Alanine; Chromatography, High Pressure Liquid; Drug Contamination; Eosinophilia-Myalgia Syndrome; Humans; Tryptophan; Tryptophanase | 1996 |
Contaminants in biotechnologically manufactured L-tryptophan.
Topics: Aldehydes; Animals; Biotechnology; Chromatography, High Pressure Liquid; Drug Contamination; Eosinophilia-Myalgia Syndrome; Oxidation-Reduction; Tryptophan | 1996 |
Diagnostic bias in clinical decision making: an example of L-tryptophan and the diagnosis of eosinophilia-myalgia syndrome.
Topics: Eosinophilia-Myalgia Syndrome; Female; Humans; Male; Multivariate Analysis; Observer Variation; Physicians; Tryptophan | 1996 |
Elevated L-kynurenine level and its normalization by prednisolone in a patient with eosinophilia-myalgia syndrome.
Topics: Anti-Inflammatory Agents; Eosinophilia-Myalgia Syndrome; Female; Humans; Kynurenine; Middle Aged; Prednisolone; Tryptophan; Tryptophan Oxygenase | 1997 |
Increased activity of the alpha 1(I) procollagen promoter in skin fibroblasts from patients with chronic eosinophilia-myalgia syndrome.
Topics: Adult; Cell Line; Chloramphenicol O-Acetyltransferase; Drug Contamination; Eosinophilia-Myalgia Syndrome; Female; Fibroblasts; Gene Expression; Genes, Reporter; Humans; Middle Aged; Procollagen; Promoter Regions, Genetic; Skin; Transfection; Tryptophan | 1997 |
EBT, a tryptophan contaminant associated with eosinophilia myalgia syndrome, is incorporated into proteins during translation as an amino acid analog.
Topics: Animals; Cell-Free System; Electrophoresis, Polyacrylamide Gel; Eosinophilia-Myalgia Syndrome; Leucine; Protein Biosynthesis; Proteins; Rabbits; Reticulocytes; Tritium; Tryptophan | 1996 |
On-line HPLC-tandem mass spectrometry analysis of contaminants of L-tryptophan associated with the onset of the eosinophilia-myalgia syndrome.
Topics: Chromatography, High Pressure Liquid; Drug Contamination; Eosinophilia-Myalgia Syndrome; Gas Chromatography-Mass Spectrometry; Tryptophan | 1997 |
Intimidation of researchers by special-interest groups.
Topics: Eosinophilia-Myalgia Syndrome; Humans; Industry; Liability, Legal; Peer Review, Research; Publishing; Research Support as Topic; Tryptophan | 1997 |
Use of tryptophanase in the detection of contaminants in EMS related L-tryptophan.
Topics: Buffers; Chromatography, High Pressure Liquid; Drug Contamination; Enzymes, Immobilized; Eosinophilia-Myalgia Syndrome; Humans; Spectrophotometry, Ultraviolet; Stereoisomerism; Tryptophan; Tryptophanase | 1997 |
Structural characterization of contaminants found in commercial preparations of melatonin: similarities to case-related compounds from L-tryptophan associated with eosinophilia-myalgia syndrome.
Topics: Chromatography, High Pressure Liquid; Disease Outbreaks; Drug Contamination; Eosinophilia-Myalgia Syndrome; Formaldehyde; Humans; Mass Spectrometry; Melatonin; Molecular Structure; Tryptophan; United States | 1998 |
Once too little, now too much.
Topics: Drug Contamination; Eosinophilia-Myalgia Syndrome; Humans; Tryptophan | 1998 |
On-line HPLC-tandem mass spectrometry structural characterization of case-associated contaminants of L-tryptophan implicated with the onset of eosinophilia myalgia syndrome.
Topics: Chromatography, High Pressure Liquid; Drug Contamination; Eosinophilia-Myalgia Syndrome; Humans; Mass Spectrometry; Tryptophan | 1998 |
L-tryptophan-related eosinophilia-myalgia syndrome possibly associated with a chronic B-lymphocytic leukemia.
Topics: Adult; Eosinophilia; Eosinophilia-Myalgia Syndrome; Fasciitis; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Tryptophan | 1998 |
Over-the-counter melatonin products and contamination.
Topics: Drug Contamination; Eosinophilia-Myalgia Syndrome; Gas Chromatography-Mass Spectrometry; Humans; Melatonin; Nonprescription Drugs; Tryptophan | 1999 |
Presence of peak X and related compounds: the reported contaminant in case related 5-hydroxy-L-tryptophan associated with eosinophilia-myalgia syndrome.
Topics: Chromatography, High Pressure Liquid; Drug Contamination; Eosinophilia-Myalgia Syndrome; Humans; Tryptophan | 1999 |
Structural characterization of case-associated contaminants peak C and FF in L-tryptophan implicated in eosinophilia-myalgia syndrome.
Topics: Chromatography, High Pressure Liquid; Drug Contamination; Eosinophilia-Myalgia Syndrome; Humans; Indoles; Mass Spectrometry; Tryptophan | 1999 |
Synthesis, formation, and occurrence of contaminants in biotechnologically manufactured L-tryptophan.
Topics: Animal Feed; Biotechnology; Drug Contamination; Eosinophilia-Myalgia Syndrome; Humans; Protein Binding; Quality Control; Serum Albumin; Tryptophan | 1999 |
Synthesis and formation of an EMS correlated contaminant in biotechnologically manufactured L-tryptophan.
Topics: Biotechnology; Chromatography, High Pressure Liquid; Disease Outbreaks; Drug Contamination; Eosinophilia-Myalgia Syndrome; Humans; Indoles; Japan; Tryptophan | 1999 |
Is there any relationship between eosinophilia myalgia syndrome (EMS) and fibromyalgia syndrome (FMS)? An analysis of clinical and immunological data.
Topics: Adult; Aged; Autoantibodies; Cells, Cultured; Cytokines; Drug Contamination; Eosinophilia-Myalgia Syndrome; Female; Fibromyalgia; Humans; Interleukin-5; Lymphocytes; Male; Middle Aged; Reference Values; Tryptophan | 1999 |
L-tryptophan contaminant 'peak E' induces the release of IL-5 and IL-10 by peripheral blood mononuclear cells from patients with functional somatic syndromes.
Topics: Adult; Case-Control Studies; Cytokines; Drug Contamination; Eosinophilia-Myalgia Syndrome; Female; Fibromyalgia; Humans; In Vitro Techniques; Interleukin-10; Interleukin-5; Leukocytes, Mononuclear; Male; Middle Aged; Risk Factors; Syndrome; Th2 Cells; Tryptophan | 2001 |
Eosinophilia-myalgia syndrome: coming to grips with a new illness.
Topics: Age Factors; Disease Outbreaks; Eosinophilia-Myalgia Syndrome; Female; History, 20th Century; Humans; Male; Population Surveillance; Prevalence; Tryptophan; United States | 1992 |
Autoantibodies to nuclear lamin C in the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion.
Topics: Administration, Oral; Adult; Antibodies, Antinuclear; Autoantibodies; Cell Nucleus; Eosinophilia-Myalgia Syndrome; Female; Fluorescent Antibody Technique; Humans; Immunoblotting; Lamin Type A; Lamins; Nuclear Proteins; Prednisone; Tryptophan | 1992 |
Demyelinating polyneuropathy in eosinophilia-myalgia syndrome.
Topics: Demyelinating Diseases; Eosinophilia-Myalgia Syndrome; Female; Humans; Male; Middle Aged; Muscles; Neural Conduction; Peripheral Nervous System Diseases; Tryptophan | 1992 |
[Eosinophilia-myalgia: new syndrome].
Topics: Brassica; Environmental Exposure; Eosinophilia-Myalgia Syndrome; Fatty Acids, Monounsaturated; Hazardous Substances; Humans; Plant Oils; Rapeseed Oil; Tryptophan | 1992 |
Eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan.
Topics: Abdominal Muscles; Adult; Eosinophilia-Myalgia Syndrome; Humans; Male; Muscles; Thorax; Tryptophan | 1992 |
L-tryptophan syndrome: histologic features of scleroderma-like skin changes.
Topics: Adult; Biopsy; Eosinophilia-Myalgia Syndrome; Female; Humans; Middle Aged; Scleroderma, Systemic; Skin; Syndrome; Tryptophan | 1992 |
From the Food and Drug Administration.
Topics: Computer Communication Networks; Eosinophilia-Myalgia Syndrome; Humans; Nonprescription Drugs; Tryptophan; United States; United States Food and Drug Administration | 1992 |
[Eosinophilia-myalgia syndrome].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Diagnosis, Differential; Eosinophilia-Myalgia Syndrome; Female; Humans; Male; Middle Aged; Prognosis; Tryptophan | 1992 |
Eosinophilia-myalgia syndrome in a child with phenylketonuria.
Topics: Child, Preschool; Eosinophilia-Myalgia Syndrome; Food Contamination; Food, Formulated; Humans; Male; Phenylketonurias; Tryptophan | 1992 |
[A case of the eosinophilia-myalgia syndrome].
Topics: Adult; Eosinophilia-Myalgia Syndrome; Female; Humans; Tryptophan | 1992 |
Central nervous system involvement in the eosinophilia-myalgia syndrome.
Topics: Central Nervous System Diseases; Eosinophilia-Myalgia Syndrome; Female; Humans; Intelligence Tests; Memory; Middle Aged; Neuropsychological Tests; Tryptophan; Verbal Learning | 1992 |
Tryptophan metabolism via the kynurenine pathway in patients with the eosinophilia-myalgia syndrome.
Topics: Adrenal Cortex Hormones; Adult; Aged; Eosinophilia-Myalgia Syndrome; Female; Humans; Interferon-gamma; Kynurenine; Male; Middle Aged; Quinolinic Acid; Scleroderma, Systemic; Tryptophan | 1992 |
3-anilino-L-alanine, structural determination of UV-5, a contaminant in EMS-associated L-tryptophan samples.
Topics: Alanine; Chromatography, High Pressure Liquid; Eosinophilia-Myalgia Syndrome; Humans; Magnetic Resonance Spectroscopy; Tryptophan | 1992 |
3-(Phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome?
Topics: Alanine; beta-Alanine; Brassica; Chromatography, High Pressure Liquid; Drug Contamination; Eosinophilia-Myalgia Syndrome; Fatty Acids, Monounsaturated; Plant Oils; Rapeseed Oil; Spain; Tryptophan; United States | 1992 |
Eosinophilia-myalgia syndrome.
Topics: Animals; Eosinophilia-Myalgia Syndrome; Humans; Spain; Tryptophan; United States | 1992 |
Identification of decomposition products of 1,1'-ethylidenebis [L-tryptophan], a compound associated with eosinophilia-myalgia syndrome.
Topics: Chromatography, Liquid; Eosinophilia-Myalgia Syndrome; Gastric Juice; Magnetic Resonance Spectroscopy; Mass Spectrometry; Models, Biological; Spectrum Analysis; Tryptophan | 1992 |
[Eosinophilia-myalgia syndrome. Clinical aspects and follow-up of 10 patients].
Topics: Adult; Aged; Biopsy; Dose-Response Relationship, Drug; Eosinophilia-Myalgia Syndrome; Female; Follow-Up Studies; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Skin; Tryptophan | 1992 |
Eosinophilia-myalgia syndrome. Natural history in a population-based cohort.
Topics: Activities of Daily Living; Adult; Aged; Cohort Studies; Eosinophilia-Myalgia Syndrome; Female; Follow-Up Studies; Humans; Male; Middle Aged; Oregon; Prospective Studies; Time Factors; Tryptophan | 1992 |
Alterations in tryptophan metabolism in the toxic oil syndrome and in the eosinophilia-myalgia syndrome.
Topics: Arthritis, Rheumatoid; Biopterins; Brassica; Eosinophilia-Myalgia Syndrome; Fatty Acids, Monounsaturated; Humans; Kynurenine; Neopterin; Plant Oils; Quinolinic Acid; Quinolinic Acids; Rapeseed Oil; Reference Values; Scleroderma, Systemic; Syndrome; Tryptophan | 1992 |
Chronic demyelinating polyneuropathy associated with eosinophilia-myalgia syndrome.
Topics: Aged; Axons; Back Pain; Biopsy; Demyelinating Diseases; Diagnosis, Differential; Eosinophilia-Myalgia Syndrome; Female; Humans; Middle Aged; Motor Neurons; Myelin Sheath; Neurologic Examination; Peripheral Nerves; Polyneuropathies; Reaction Time; Sensation; Sleep Initiation and Maintenance Disorders; Tryptophan | 1992 |
L-tryptophan-associated eosinophilic fasciitis prior to the 1989 eosinophilia-myalgia syndrome outbreak.
Topics: Case-Control Studies; Disease Outbreaks; Eosinophilia; Eosinophilia-Myalgia Syndrome; Fasciitis; Female; Humans; Male; Middle Aged; Myositis; Tryptophan | 1992 |
Tryptophan induced eosinophilia-myalgia syndrome: clinical and microscopic findings.
Topics: Adult; Eosinophilia-Myalgia Syndrome; Fibroblasts; Humans; Male; Microscopy, Electron; Skin; Tryptophan | 1992 |
Gastrointestinal involvement in L-tryptophan (L-Trp) associated eosinophilia-myalgia syndrome (EMS).
Topics: Biopsy; Chronic Disease; Diagnosis, Differential; Diarrhea; Digestive System; Eosinophilia-Myalgia Syndrome; Female; Gastrointestinal Diseases; Humans; Middle Aged; Tryptophan; Weight Loss | 1992 |
Pulmonary manifestations of the eosinophilia-myalgia syndrome associated with tryptophan ingestion.
Topics: Adult; Bronchoalveolar Lavage Fluid; Eosinophilia-Myalgia Syndrome; Female; Humans; Lung; Male; Middle Aged; Oxygen; Pulmonary Diffusing Capacity; Respiratory Mechanics; Respiratory Tract Diseases; Tryptophan | 1992 |
Dyspnea and pulmonary function in the L-tryptophan-associated eosinophilia-myalgia syndrome.
Topics: Adult; Aged; Dyspnea; Eosinophilia-Myalgia Syndrome; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Pulmonary Diffusing Capacity; Respiratory Mechanics; Total Lung Capacity; Tryptophan; Vital Capacity | 1992 |
Eosinophilia-myalgia syndrome: myopathic electrodiagnostic characteristics.
Topics: Aged; Biopsy; Electromyography; Eosinophilia-Myalgia Syndrome; Female; Humans; Middle Aged; Muscles; Tryptophan | 1992 |
[Muscle pain, scleroderma-like skin changes and eosinophilia following administration of a psychotropic drug].
Topics: Depressive Disorder; Diagnosis, Differential; Eosinophilia-Myalgia Syndrome; Female; Humans; Middle Aged; Skin; Sleep Initiation and Maintenance Disorders; Tryptophan | 1992 |
Search for contaminant in EMS outbreak goes slowly.
Topics: Drug Contamination; Eosinophilia-Myalgia Syndrome; Humans; Japan; National Institutes of Health (U.S.); Recombinant Proteins; Tryptophan; United States | 1992 |
[Polyneuropathy and fasciitis in eosinophilia-myalgia syndrome].
Topics: Depressive Disorder; Diagnosis, Differential; Eosinophilia-Myalgia Syndrome; Fasciitis; Female; Humans; Middle Aged; Myelin Sheath; Neurologic Examination; Peripheral Nerves; Polyneuropathies; Reaction Time; Synaptic Transmission; Tryptophan | 1991 |
L-tryptophan-induced eosinophilia-myalgia syndrome. II. Partial correction of abnormal tryptophan metabolism by pyridoxine.
Topics: Adult; Eosinophilia-Myalgia Syndrome; Female; Humans; Hydroxyindoleacetic Acid; Kynurenine; Middle Aged; Pyridoxine; Serotonin; Tryptophan | 1991 |
Eosinophilia-myalgia syndrome in L-tryptophan-exposed patients.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Cohort Studies; Eosinophilia-Myalgia Syndrome; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Seasons; Tryptophan | 1992 |
[A case from practice (233). Eosinophilic myalgia syndrome].
Topics: Diagnosis, Differential; Eosinophilia-Myalgia Syndrome; Female; Humans; Middle Aged; Scleroderma, Systemic; Tryptophan | 1991 |
L-tryptophan-induced eosinophilia-myalgia syndrome. I. Report of two cases with pseudoxanthoma-elasticum-like skin changes.
Topics: Eosinophilia-Myalgia Syndrome; Female; Humans; Middle Aged; Pseudoxanthoma Elasticum; Scleroderma, Localized; Skin; Tryptophan | 1991 |
Detection of antineutrophil cytoplasmic antibody in a patient with L-tryptophan induced eosinophilia-myalgia syndrome.
Topics: Antibodies; Cytoplasm; Eosinophilia-Myalgia Syndrome; Female; Humans; Methylprednisolone; Middle Aged; Neutrophils; Tryptophan | 1991 |
[Topics on eosinophilia-myalgia syndrome].
Topics: Adult; Animals; Bacillus; Drug Contamination; Eosinophilia-Myalgia Syndrome; Humans; Male; Reference Standards; Tryptophan | 1991 |
Central and peripheral nervous system involvement in the L-tryptophan associated eosinophilia myalgia syndrome.
Topics: Aged; Brain; Central Nervous System; Electromyography; Electrophysiology; Eosinophilia-Myalgia Syndrome; Female; Humans; Magnetic Resonance Imaging; Neural Conduction; Peripheral Nerves; Tryptophan | 1991 |
Simultaneous development of two cases of eosinophilia-myalgia syndrome with the same lot of L-tryptophan in Japan.
Topics: Aged; Eosinophilia-Myalgia Syndrome; Female; Humans; Japan; Skin; Skin Diseases; Tryptophan | 1991 |
Episodic eosinophilia-myalgia-like syndrome in a patient without L-tryptophan use: association with eosinophil activation and increased serum levels of granulocyte-macrophage colony-stimulating factor.
Topics: Angioedema; Eosinophilia-Myalgia Syndrome; Eosinophils; Flow Cytometry; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunophenotyping; Male; Middle Aged; Prednisone; Recurrence; Tryptophan | 1991 |
Biotechnology. Yellow light on L-tryptophan.
Topics: Animals; Eosinophilia-Myalgia Syndrome; Humans; Rats; Tryptophan | 1991 |
Endogenous formation of 1-methyl-1,2,3,4-tetrahydro-beta-carboline-3- carboxylic acid in man as the possible causative substance of eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan.
Topics: Acetaldehyde; Adult; Aldehyde Dehydrogenase; Carbolines; Eosinophilia-Myalgia Syndrome; Ethanol; Female; Humans; Isoenzymes; Male; Tryptophan | 1991 |
Upper extremity contractures in a patient with eosinophilia-myalgia syndrome.
Topics: Arm; Eosinophilia-Myalgia Syndrome; Female; Humans; Middle Aged; Muscle Contraction; Range of Motion, Articular; Tryptophan | 1991 |
Eosinophilia caused by administration of L-tryptophan to animals with adrenal dysfunction.
Topics: Administration, Oral; Adrenal Glands; Adrenalectomy; Animals; Eosinophilia-Myalgia Syndrome; Eosinophils; Injections, Subcutaneous; Leukocyte Count; Male; Metyrapone; Mice; Mice, Inbred BALB C; Rats; Rats, Inbred Strains; Species Specificity; Tryptophan | 1991 |
[Eosinophilic myalgia from L-tryptophan].
Topics: Eosinophilia-Myalgia Syndrome; Female; France; Humans; Middle Aged; Tryptophan | 1990 |
Abnormalities of the coronary arteries, neural structures and conduction system of the heart observed postmortem in the eosinophilia-myalgia syndrome, with a discussion of comparative findings from the toxic oil syndrome.
Topics: Aged; Coronary Vessels; Dietary Fats, Unsaturated; Eosinophilia-Myalgia Syndrome; Heart Conduction System; Humans; Male; Middle Aged; Nervous System; Syndrome; Tryptophan | 1991 |